Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 63

Sort by

Sort Order Select

Journal Articles

Cytokine Release Syndrome in HSCT May Affect Dendritic Cell Recovery and Early Development of aGVHD

Xin Liu, Bohan Li, Shengqin Cheng, Jinlan Zhao, Peifang Xiao, Jun Lu, Jie Li, Yuanyuan Tian, Shaoyan Hu

Blood (2024) 144 (Supplement 1): 7373.

https://doi.org/10.1182/blood-2024-210154

Published: 2024

Journal Articles

Real-World Safety and Effectiveness of Letermovir in Pediatric Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation

Qingwei Wang, Zhiheng LI, Yixin Hu, Li Gao, Shengqin Cheng, Qi Ji, Senlin Zhang, Jun Lu, Jie Li, Peifang Xiao, Shaoyan Hu

Blood (2024) 144 (Supplement 1): 7297.

https://doi.org/10.1182/blood-2024-210629

Published: 2024

Journal Articles

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

Blood (2024) 144 (Supplement 1): 6925.

https://doi.org/10.1182/blood-2024-205155

Published: 2024

Journal Articles

TRA/D Rearrangements As a New Potential Alternative Prognostic Biomarker in Pediatric B-Cell Acute Lymphoblastic Leukemia

Jiajia Zheng, Xinni Bian, Jun Lu, Peifang Xiao, Hailong He, Yi Wang, Jie Li, Junjie Fan, Yanhua Yao, Jing Ling, Yiting Wang, Nan Chen, Xingping Lang, Jingjing Feng, Xiaojun Chen, Huafei Chen, Sheng Xiao, Sheng Xiao, Shaoyan Hu

Blood (2024) 144 (Supplement 1): 5931.

https://doi.org/10.1182/blood-2024-212299

Published: 2024

Journal Articles

Dual-Risk Adjusted Therapy for Elderly Patients with Multiple Myeloma Based on Dynamic Frailty Assessment and R-ISS: A Prospective Clinical Trial

Hua Xue, Jianmei Xu, Jie Li, Xiaohui Suo, Haisheng Liu, Juan Wang, Jing Wang, Songying Zhao, Huimei Guo, Yao Liu

Blood (2024) 144 (Supplement 1): 7057.

https://doi.org/10.1182/blood-2024-200398

Published: 2024

Journal Articles

Time-Limited of Zanubrutinib, Rituximab and Lenalidomide (ZR2) Regimen for the Treatment of Super-Elderly Diffuse Large B-Cell Lymphoma (DLBCL): A Prospective, Exploratory Clinical Study

Jie Zou, Xiaoning Yu, Xiaoxia Chu, Ji Ma, Zengjun Li, Chunyan Chen, Yan Liu, Jian Xing, Zhongliang Sun, Chunyan Ji, Jie Li

Blood (2024) 144 (Supplement 1): 1732.

https://doi.org/10.1182/blood-2024-207021

Published: 2024

Journal Articles

Analysis of Safety and Efficacy of Avapritinib As Targeted Therapy for Pediatric Acute Myeloid Leukemia Patients with KIT Mutation after Transplantation

Qingwei Wang, Li Gao, Peifang Xiao, Jun Lu, Jie Li, Yanhua Yao, Shaoyan Hu

Blood (2023) 142 (Supplement 1): 7048.

https://doi.org/10.1182/blood-2023-187764

Published: 2023

Journal Articles

The Influence of Methotrexate-Related Transporter and Metabolizing Enzyme Gene Polymorphisms on Peri-Engraftment Syndrome and Graft-Versus-Host Disease after Haplo-Hematopoietic Stem Cell Transplantation in Pediatric Patients with Malignant Hematological Diseases

Qi Ji, Yongping Zhang, Yixin Hu, Lixia Liu, Shanbo Cao, Li Gao, Bohan Li, Yuanyuan Tian, Lingjun Kong, Shuiyan Wu, Jing Ling, Peifang Xiao, Jun Lu, Jie Li, Yanhua Yao, Jiayue Qin, Shaoyan Hu

Blood (2023) 142 (Supplement 1): 6960.

https://doi.org/10.1182/blood-2023-185431

Published: 2023

Journal Articles

Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma：a Multicenter Real-World Study

Na Liu, Luqun WANG, Rentong Liu, Yuping Zhong, Xianqi Feng, Zhongliang Sun, Jie Li, Fanjun Meng, Junjie MA, Changyong Yuan, Hao Li, Ling Wang, Zhilong Xu, Jie Yu, Hao Zhang, Chen Chunyan

Blood (2023) 142 (Supplement 1): 6632.

https://doi.org/10.1182/blood-2023-179687

Published: 2023

Journal Articles

Successful Use of Haploid Hematopoietic Stem Cell Transplantation for Severe Glanzmann's Thrombasthenia

Shuran Wang, Peifang Xiao, Jie Li, Jun Lu, Yixin Hu, Shaoyan Hu, Jing Ling

Blood (2023) 142 (Supplement 1): 2168.

https://doi.org/10.1182/blood-2023-187966

Published: 2023

Journal Articles

A Phase I Study of Venetoclax Combined with Homoharringtonine, Cytarabine, and G-CSF for the Treatment of Pediatric De Novo Acute Myeloid Leukemia

Shengqin Cheng, Li Gao, Yi Wang, Peifang Xiao, Hailong He, Jun Lu, Jie Li, Yixin Hu, Liyan Fan, Raul C. Ribeiro, Cheng Cheng, Shaoyan Hu

Blood (2023) 142 (Supplement 1): 2900.

https://doi.org/10.1182/blood-2023-188040

Published: 2023

Journal Articles

Cooperative Super-Enhancer Inactivation through Loss of Crebbp and KMT2D Skews B Cell Fate Decisions and Yields T Cell-Depleted Lymphomas

Jie Li, Christopher Chin, Hsia-Yuan Ying, Cem Meydan, Matthew Teater, Min Xia, Pedro Farinha, Katsuyoshi Takata, Chi-Shuen Chu, Martin A Rivas, Amy Chadburn, Christian Steidl, David W. Scott, Robert G. Roeder, Christopher Mason, Wendy BÃ©guelin, Ari M Melnick

Blood (2023) 142 (Supplement 1): 2776.

https://doi.org/10.1182/blood-2023-174501

Published: 2023

Journal Articles

Single Institution Observational Study of Risk-Adapted Therapy for Children with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia

Yixin Hu, Li Gao, Peifang Xiao, Hailong He, Yi Wang, Liyan Fan, Shengqin Cheng, Jing Ling, Jie Li, Junjie Fan, Yanhua Yao, Xin Ding, Jian Pan, Jun Lu, Raul C. Ribeiro, Shaoyan Hu

Blood (2022) 140 (Supplement 1): 11809.

https://doi.org/10.1182/blood-2022-170708

Published: 2022

Journal Articles

The N-Terminal Amino Acid Mutation Site Is a Potential Biological Marker for Precise Risk Stratification in Pediatric Patients with CEBPA-Dm AML

Shengqin Cheng, Yixin Hu, Li Gao, Liyan Fan, Yi Wang, Hailong He, Jie Li, Jun Lu, Peifang Xiao, Shaoyan Hu

Blood (2022) 140 (Supplement 1): 11841.

https://doi.org/10.1182/blood-2022-170955

Published: 2022

Journal Articles

Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study

Blood (2022) 140 (Supplement 1): 9544–9545.

https://doi.org/10.1182/blood-2022-169274

Published: 2022

Journal Articles

Association between Haploidentical Hematopoietic Stem Cell Transplantation Combined with an Umbilical Cord Blood Unit and Graft-Versus-Host Disease in Pediatric Patients with Acquired Severe Aplastic Anemia

Di Yao, Jie Li, Bohan Li, Jun Lu, Jing Ling, Defei Zheng, Peifang Xiao, Lijun Meng, Shaoyan Hu, Yuanyuan Tian

Blood (2022) 140 (Supplement 1): 7634–7635.

https://doi.org/10.1182/blood-2022-170554

Published: 2022

Journal Articles

Zanubrutinib PLUS RCHOP(ZR-CHOP) Regimen Achieves High Complete Response Rate in the Treatment of Newly-Diagnosed Double-Expression Diffuse Large B Cell Lymphoma

Qiang He, Linna Xie, Rongrong Zhao, Ji Ma, Hui Wang, Jie Li, Chuanli Zhao, Y. Lynn Wang, Zengjun Li

Blood (2022) 140 (Supplement 1): 6614–6615.

https://doi.org/10.1182/blood-2022-168859

Published: 2022

Journal Articles

Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion

Blood (2020) 136 (6): 755–759.

https://doi.org/10.1182/blood.2020007079

Published: 2020

Includes: Supplemental data

Journal Articles

Outcome and Genomic Characteristics of Non-Down Syndrome Acute Megakaryoblastic Leukemia in Children Treated with Low-Dose Chemotherapy for Induction Remission

Yixin Hu, MD, Li Gao, MD, Aili Chen, MD, Jun Lu, MD, Jie Li, MD, Hailong He, MD, Yi Wang, MD PhD, Peifang Xiao, MD, Qianfei Wang, PhD, Raul Ribeiro, MD, Shaoyan Hu, MD PhD

Blood (2019) 134 (Supplement_1): 2613.

https://doi.org/10.1182/blood-2019-129572

Published: 2019

Journal Articles

Low Levels of Plasmacytoid Dendritic Cells at the Time of Engraftment Are a Valuable Severe aGVHD Indicator in Children Undergoing Allogeneic Stem Cell Transplantation

Bohan Li, Xinran Chu, Lijun Meng, PhD, Peifang Xiao, MD, Jie Li, MD, Jun Lu, MD, Yi Zhang, MD PhD, Shaoyan Hu, MD PhD

Blood (2019) 134 (Supplement_1): 3288.

https://doi.org/10.1182/blood-2019-128191

Published: 2019

NARROW

Cytokine Release Syndrome in HSCT May Affect Dendritic Cell Recovery and Early Development of aGVHD

Real-World Safety and Effectiveness of Letermovir in Pediatric Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

TRA/D Rearrangements As a New Potential Alternative Prognostic Biomarker in Pediatric B-Cell Acute Lymphoblastic Leukemia

Dual-Risk Adjusted Therapy for Elderly Patients with Multiple Myeloma Based on Dynamic Frailty Assessment and R-ISS: A Prospective Clinical Trial

Time-Limited of Zanubrutinib, Rituximab and Lenalidomide (ZR2) Regimen for the Treatment of Super-Elderly Diffuse Large B-Cell Lymphoma (DLBCL): A Prospective, Exploratory Clinical Study

Analysis of Safety and Efficacy of Avapritinib As Targeted Therapy for Pediatric Acute Myeloid Leukemia Patients with KIT Mutation after Transplantation

The Influence of Methotrexate-Related Transporter and Metabolizing Enzyme Gene Polymorphisms on Peri-Engraftment Syndrome and Graft-Versus-Host Disease after Haplo-Hematopoietic Stem Cell Transplantation in Pediatric Patients with Malignant Hematological Diseases

Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma：a Multicenter Real-World Study

Successful Use of Haploid Hematopoietic Stem Cell Transplantation for Severe Glanzmann's Thrombasthenia

A Phase I Study of Venetoclax Combined with Homoharringtonine, Cytarabine, and G-CSF for the Treatment of Pediatric De Novo Acute Myeloid Leukemia

Cooperative Super-Enhancer Inactivation through Loss of Crebbp and KMT2D Skews B Cell Fate Decisions and Yields T Cell-Depleted Lymphomas

Single Institution Observational Study of Risk-Adapted Therapy for Children with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia

The N-Terminal Amino Acid Mutation Site Is a Potential Biological Marker for Precise Risk Stratification in Pediatric Patients with CEBPA-Dm AML

Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study

Association between Haploidentical Hematopoietic Stem Cell Transplantation Combined with an Umbilical Cord Blood Unit and Graft-Versus-Host Disease in Pediatric Patients with Acquired Severe Aplastic Anemia

Zanubrutinib PLUS RCHOP(ZR-CHOP) Regimen Achieves High Complete Response Rate in the Treatment of Newly-Diagnosed Double-Expression Diffuse Large B Cell Lymphoma

Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion

Outcome and Genomic Characteristics of Non-Down Syndrome Acute Megakaryoblastic Leukemia in Children Treated with Low-Dose Chemotherapy for Induction Remission

Low Levels of Plasmacytoid Dendritic Cells at the Time of Engraftment Are a Valuable Severe aGVHD Indicator in Children Undergoing Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only